Annual Current Liabilities
$29.51 M
+$12.89 M+77.60%
31 December 2023
Summary:
Day One Biopharmaceuticals annual total current liabilities is currently $29.51 million, with the most recent change of +$12.89 million (+77.60%) on 31 December 2023. During the last 3 years, it has risen by +$27.51 million (+1378.36%). DAWN annual current liabilities is now at all-time high.DAWN Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Liabilities
$39.74 M
-$53.96 M-57.59%
30 September 2024
Summary:
Day One Biopharmaceuticals quarterly total current liabilities is currently $39.74 million, with the most recent change of -$53.96 million (-57.59%) on 30 September 2024. Over the past year, it has increased by +$15.27 million (+62.39%). DAWN quarterly current liabilities is now -57.59% below its all-time high of $93.71 million, reached on 30 June 2024.DAWN Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
DAWN Current Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +77.6% | +62.4% |
| 3 y3 years | +1378.4% | +557.4% |
| 5 y5 years | - | - |
DAWN Current Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +1378.4% | -57.6% | +557.4% |
| 5 y | 5 years | at high | +1378.4% | -57.6% | +1891.2% |
| alltime | all time | at high | +1378.4% | -57.6% | +1891.2% |
Day One Biopharmaceuticals Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $39.74 M(-57.6%) |
| June 2024 | - | $93.71 M(+214.0%) |
| Mar 2024 | - | $29.84 M(+1.1%) |
| Dec 2023 | $29.51 M(+77.6%) | $29.51 M(+20.6%) |
| Sept 2023 | - | $24.48 M(-0.2%) |
| June 2023 | - | $24.51 M(+7.3%) |
| Mar 2023 | - | $22.85 M(+37.5%) |
| Dec 2022 | $16.61 M | $16.61 M(-9.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2022 | - | $18.27 M(+42.8%) |
| June 2022 | - | $12.80 M(+56.5%) |
| Mar 2022 | - | $8.18 M(-5.6%) |
| Dec 2021 | $8.66 M(+333.7%) | $8.66 M(+43.2%) |
| Sept 2021 | - | $6.05 M(+29.7%) |
| June 2021 | - | $4.66 M(+52.1%) |
| Mar 2021 | - | $3.07 M(+53.6%) |
| Dec 2020 | $2.00 M(-1.2%) | $2.00 M |
| Dec 2019 | $2.02 M | - |
FAQ
- What is Day One Biopharmaceuticals annual total current liabilities?
- What is the all time high annual current liabilities for Day One Biopharmaceuticals?
- What is Day One Biopharmaceuticals annual current liabilities year-on-year change?
- What is Day One Biopharmaceuticals quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Day One Biopharmaceuticals?
- What is Day One Biopharmaceuticals quarterly current liabilities year-on-year change?
What is Day One Biopharmaceuticals annual total current liabilities?
The current annual current liabilities of DAWN is $29.51 M
What is the all time high annual current liabilities for Day One Biopharmaceuticals?
Day One Biopharmaceuticals all-time high annual total current liabilities is $29.51 M
What is Day One Biopharmaceuticals annual current liabilities year-on-year change?
Over the past year, DAWN annual total current liabilities has changed by +$12.89 M (+77.60%)
What is Day One Biopharmaceuticals quarterly total current liabilities?
The current quarterly current liabilities of DAWN is $39.74 M
What is the all time high quarterly current liabilities for Day One Biopharmaceuticals?
Day One Biopharmaceuticals all-time high quarterly total current liabilities is $93.71 M
What is Day One Biopharmaceuticals quarterly current liabilities year-on-year change?
Over the past year, DAWN quarterly total current liabilities has changed by +$15.27 M (+62.39%)